Summary:
The purpose of this research study is to evaluate the safety and tolerability of BTD-001, an investigational medication, in subjects with Idiopathic Hypersomnia (IH).
Qualified Participants Must:
• 18-70 years old
•
Have a diagnosis of Idiopathic Hypersomnia (IH) by a health care provider
•
No diagnosis of any other sleep disorder
• Be otherwise in good health